Provided by Tiger Trade Technology Pte. Ltd.

Doximity, Inc.

50.56
-0.5100-1.00%
Post-market: 51.060.5000+0.99%18:07 EST
Volume:1.77M
Turnover:89.73M
Market Cap:9.52B
PE:40.49
High:51.78
Open:51.20
Low:50.23
Close:51.07
52wk High:85.21
52wk Low:46.04
Shares:188.27M
Float Shares:133.13M
Volume Ratio:1.15
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.25
EPS(LYR):1.19
ROE:24.61%
ROA:13.10%
PB:8.69
PE(LYR):42.33

Loading ...

Berenberg Bank Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 29

Doximity Director Timothy S. Cabral Reports Disposal of Common Shares

Reuters
·
Nov 25

Dr. Martens Earnings Call: Mixed Sentiments and Strategic Moves

TIPRANKS
·
Nov 22

BUZZ-U.S. STOCKS ON THE MOVE-IES Holding, Eli Lilly, Alphabet

Reuters
·
Nov 22

BUZZ-Doximity rises after Raymond James upgrades to 'strong buy'

Reuters
·
Nov 22

Doximity Shares up 2.6% Premarket After Raymond James Raises to Strong Buy From Outperform

THOMSON REUTERS
·
Nov 21

Doximity Inc : Raymond James Raises to Strong Buy From Outperform; Cuts Target Price to $65 From $75

THOMSON REUTERS
·
Nov 21

Dr. Martens Plc (DOCS) Gets a Hold from Barclays

TIPRANKS
·
Nov 21

Goldman Sachs Sticks to Their Hold Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 21

Peel Hunt Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 21

Can Doximity’s (DOCS) Share Buybacks and Earnings Strength Tell Us More About Its Growth Vision?

Simply Wall St.
·
Nov 20

Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive'

Benzinga_recent_news
·
Nov 13

Dr. Martens Directors Participate in Share Incentive Plan

TIPRANKS
·
Nov 12

Dr. Martens Plc (DOCS) Receives a Hold from RBC Capital

TIPRANKS
·
Nov 12

Analysts Conflicted on These Healthcare Names: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Sutro Biopharma (STRO)

TIPRANKS
·
Nov 11

Doximity Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Nov 11

OpenAI considers consumer health tools in push beyond core AI offerings, Business Insider reports

Reuters
·
Nov 10

Stock Track | Doximity Plummets 14.73% as Q2 Beat Overshadowed by Disappointing Growth Outlook

Stock Track
·
Nov 08

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Cartesian Therapeutics (RNAC) and Anixa Biosciences (ANIX)

TIPRANKS
·
Nov 07

Stock Track | Doximity Plummets 9.70% in Pre-market Following Q2 Results and Disappointing Growth Outlook

Stock Track
·
Nov 07